Fibromyalgia Trial, Recruiting NCT07270276 Sponsor: Beth Israel Deaconess Medical Center Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT07270276
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 80 years old
  • You have active "trigger points" (tight, painful knots in the muscle) in the upper part of your trapezius muscle (the muscle running along the top of your shoulders and neck)
  • If you need extra pain relief, you are able to manage it using only acetaminophen (such as Tylenol), though any pain medications you are already taking at a stable dose may be continued

Who may not be able to join:

  • You have many trigger points in the trapezius muscle and the doctor believes this would make it hard to tell whether the treatment is working
  • You have pain that travels down from your neck (nerve-related pain), or a nerve or muscle disease that could affect how results are interpreted
  • You have fibromyalgia or another condition that causes widespread, generalized pain throughout your body
  • You have used opioid pain medications (such as codeine, oxycodone, or morphine) in the past 3 months
  • You currently have a substance use disorder
  • You take certain medications — such as some antidepressants, nerve pain medications, or anti-seizure drugs — and have not been on a stable dose for at least two weeks before the study, or are unwilling to keep the dose the same throughout the study (confirm with trial site for the full list of affected medications)
  • You have a skin allergy or sensitivity that would prevent sticky electrode pads from being placed on your skin
  • You have a serious physical or mental health condition that the study doctor believes would prevent you from safely participating
  • You take blood-thinning medications such as warfarin (Coumadin), clopidogrel (Plavix), or direct oral anticoagulants — note that aspirin is acceptable
  • You have had needle-based trigger point treatment on the trigger point being studied within the past six weeks
  • Your Body Mass Index (BMI) is over 35 (confirm with trial site if unsure)
  • There is any other reason the study doctor believes you would not be able to complete the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
1 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Excitability threshold tracking (TT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov